Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Antiseizure medications

2 evidence topics · 1 source

Primidone in the MDS evidence-based review

“Propranolol and primidone” (opens the source at this quote in a new tab)

“clinically useful” (opens the source at this quote in a new tab)

Topiramate dose qualification in the MDS review

“Propranolol and primidone were classified as clinically useful, similar to Topiramate, but only for doses higher than 200 mg/day.” (opens the source at this quote in a new tab)